PK

Perumal Kalaiselvan Sivaranjini

Active Director Director DIN 10416477
DIN 10416477 First appointment Dec 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Perumal Kalaiselvan Sivaranjini

Data last updated:

Perumal Kalaiselvan Sivaranjini is a Director at Nala Hospital Private Limited (since 2023). The company operates in Healthcare.

DIN 10416477
Primary Designation Director
Industry Healthcare
First Appointment 26 Dec 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nala Hospital Private Limited U86100TZ2023PTC030214
Director26 Dec 20232023Active

Board colleagues of Perumal Kalaiselvan Sivaranjini

NameDINCompanyDesignation
Nagendran Muralidharan10416479Nala Hospital Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nala Hospital Private Limited
Premium access

Shareholding and investment profile for Perumal Kalaiselvan Sivaranjini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Perumal Kalaiselvan Sivaranjini

Perumal Kalaiselvan Sivaranjini currently holds 1 directorship: Nala Hospital Private Limited (Director, since 26 Dec 2023).

Perumal Kalaiselvan Sivaranjini was first appointed on 26 Dec 2023 as Director at Nala Hospital Private Limited.

The current boards of Perumal Kalaiselvan Sivaranjini's companies include Nagendran Muralidharan (Nala Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available